Moleculin Biotech, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.67
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.27
|
-0.30
|
-0.03
|
-11.11%
|
|
2022-06-30
|
-0.25
|
-0.24
|
0.01
|
4.00%
|
|
2022-03-31
|
-0.21
|
-0.24
|
-0.03
|
-14.29%
|
|
2021-12-31
|
-0.21
|
-0.09
|
0.12
|
57.14%
|
|
2021-09-30
|
-0.20
|
-0.15
|
0.05
|
25.00%
|
|
2021-06-30
|
-0.19
|
-0.15
|
0.04
|
21.05%
|
|
2021-03-31
|
-0.23
|
-0.20
|
0.03
|
13.04%
|
|
2020-12-31
|
-0.58
|
-0.26
|
0.32
|
55.17%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.78
|
|
2021-12-31
|
-0.59
|
|
2020-12-31
|
-1.76
|
|
2019-12-31
|
-2.04
|
|
2018-12-31
|
-0.96
|
|
2017-12-31
|
-0.81
|